Hospira Reports First-Quarter 20...($88.1 $84.4 4.4 % ...),Health

Date:4/28/2009

$88.1 $84.4 4.4 % ====== ====== Included in the reported Income before income taxes above, are the following charges: A -- Americas Project Fuel restructuring and optimization $7.6 $ - Integration-related - 0.4 Amortization of Mayne Pharma intangible assets 4.5 5.2 Facilities restructuring and optimization 11.7 7.8 ------ ------ Total Americas 23.8 13.4 B -- Europe, Middle East & Africa Project Fuel restructuring and optimization 0.2 - Integration-related - 5.4 Amortization of Mayne Pharma intangible assets 5.0 5.8 ------ ------ Total Europe, Middle East & Africa 5.2 11.2 C -- Asia Pacific Project Fuel restructuring and optimization 0.5 - Integration-related - 1.6 Amortization of Mayne Pharma intangible assets 3.5 4.7 ------ ------ Total Asia Pacific 4.0 6.3 D -- Corporate functions Project Fuel restructuring and optimization 2.2 - Integration-related - 2.6 ------ ------ Total Corporate functions 2.2 2.6
'/>"/>

SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. Hospira to Host Conference Call for First-Quarter 2009 Results
2. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
3. Hospira Expands Board of Directors
4. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
5. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
6. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
7. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
8. Hospira Names Ken Meyers to Lead Human Resources
9. Hospira Reports Third-Quarter 2008 Results
10. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
11. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection